Skip to main content

Table 4 Recommendations and Suggestions of ARIA México 2014 to be reinforced per specialty

From: How an online survey on the treatment of allergic rhinitis and its impact on asthma (ARIA) detected specialty-specific knowledge-gaps

 

Recommendations* or Suggestions* to be reinforced per specialty

Allergist

S: Indicate exclusive breastfeeding to prevent allergy

S: Oral LTRAs can be used for treatment of AR

ENT

S: Indicate exclusive breastfeeding to prevent allergy

S: The use of intranasal GCS is suggested over the use of oral H1-antihistamines in AR treatment

R: Intramuscular GCS are not recommended for treatment of AR?

S: In patients with AR and asthma Anti-IgE monoclonal antibodies can be used for the treatment of asthma.

Pulmonologist

S: Indicate exclusive breastfeeding to prevent allergy

S:Infants and preschool children should avoid exposure to HDM to reduce the risk of developing HDM allergy/asthma.

S: Nasal washes can be indicated as an integral part of the treatment of AR. (69%)

S: The use of oral H1-antihistamines is suggested over the use of oral LTRAs in AR treatment.

S: Intranasal antihistamines are suggested over IN-chromones in AR treatment

S: Intraocular H1-antiH be used for the treatment of ocular symptoms in patients with ARC

Pediatrician

S: The use of oral H1-antihistamines is suggested over the use of oral LTRAs in AR treatment.

R: The use of intranasal GCS is recommended over the use of oral LTRAs in AR treatment.

S: Intranasal antihistamines are suggested over IN-chromones in AR treatment

S: Intraocular H1-antiH be used for the treatment of ocular symptoms in patients with ARC

S: In patients with AR and asthma Anti-IgE monoclonal antibodies can be used for the treatment of asthma.

GP

S: Nasal washes can be indicated as an integral part of the treatment of AR.

S: The use of oral H1-antihistamines is suggested over the use of intranasal H1 antihistamines

S: Oral LTRAs can be used for treatment of AR

S: The use of oral H1-antihistamines is suggested over the use of oral LTRAs in AR treatment.

S: The use of intranasal GCS is suggested over the use of oral H1-antihistamines in AR treatment

R: The use of intranasal GCS is recommended over the use of intranasal H1-antihistamines and LTRAs in AR treatment

S: Intranasal antihistamines are suggested over IN-chromones in AR treatment

S: Intraocular H1-antiH be used for the treatment of ocular symptoms in patients with ARC

S: In patients with AR and asthma Anti-IgE monoclonal antibodies can be used for the treatment of asthma.

All

S:No allergen-avoidance diets should be used in pregnant or breastfeeding women

S: infants and pre-school children without animal dander allergy can have pets in their homes

S: Oral H1-antihistamines should NOT be used in preschool children with other allergic diseases for the prevention of wheezing or asthma

S: intranasal H1-antihistamines can be used for the treatment of AR

S: intranasal chromones can be used in AR treatment

S: Intranasal decongestant can be used for AR treatment, but only in a short cycle.

S: We suggest oral H1 antihistamines as regular AR treatment, not combined with decongestant

S: Intraocular chromones can be used for the treatment of ocular Sx in patients with ARC

S: In patients with AR and asthma: Oral H1 antihistamines with or without decongestants, intranasal GCS or LTRAs should NOT be used for the treatment of asthma.

  1. * For recommendations: > 20% opted for the non-recommended alternative.
  2. ** For suggestions: > 30% opted for the non-suggested alternative.